Dublin, April 08, 2019 (GLOBE NEWSWIRE) -- The "Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024.
Market growth is largely driven by factors such as the growing global prevalence of kidney diseases and urinary tract infections, the shift towards automation in sediment analysis, and the increasing adoption of point-of-care urinalysis. Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market.
On the other hand, the high cost of automated analyzers affects market penetration in emerging economies, which, in turn, challenges overall market growth to a certain extent. In this report, the urinalysis market is segmented on the basis of product, test types, applications, end users, and regions.
The major players operating in this market are Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Biorad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China).
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Urinalysis: Market Overview
4.2 North America: Urinalysis Market, by Product (2019)
4.3 Geographical Snapshot of the Urinalysis Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Global Prevalence of Kidney Diseases and Urinary Tract Infections
5.2.1.2 Shift Towards Automation in Sediment Analysis
5.2.1.3 Increasing Adoption of Point-Of-Care Urinalysis
5.2.2 Opportunities
5.2.2.1 Integrated Systems for Urinalysis
5.2.2.2 Emerging Economies
5.2.3 Challenges
5.2.3.1 High Cost of Automated Analyzers Affecting Market Penetration in Emerging Economies
6 Urinalysis Market, by Product
6.1 Introduction
6.2 Consumables
6.2.1 Pregnancy & Fertility Kits
6.2.1.1 Need for Rapid Pregnancy Testing to Drive Market Growth
6.2.2 Dipsticks
6.2.2.1 Dipsticks are Used Regularly Due to Their Low Cost and Ease of Use
6.2.3 Disposables
6.2.3.1 Wide Usage of Urine Collection Cups Will Drive the Market for Disposables
6.2.4 Reagents
6.2.4.1 Increasing Use of Controls and Calibrators to Drive Market Growth
6.3 Instruments
6.3.1 Automated Urine Analyzers
6.3.1.1 Biochemical Urine Analyzers
6.3.1.1.1 Increasing Incidence of Kidney Diseases and Urinary Tract Infections Will Increase the Demand for Automated Biochemical Analyzers
6.3.1.2 Sediment Urine Analyzers
6.3.1.2.1 Microscopy Analyzers
6.3.1.2.1.1 Increased Adoption of Automated Microscopy Analyzers to Drive Market Growth
6.3.1.2.2 Flow Cytometry Analyzers
6.3.1.2.2.1 Accuracy and Sensitivity of Flow Cytometry Technique to Drive the Adoption of These Analyzers
6.3.1.3 Integrated Urine Analyzers
6.3.1.3.1 Higher Workload in Hospitals and Laboratories to Drive the Adoption of Integrated Systems
6.3.2 Semi-Automated Urine Analyzers
6.3.2.1 Semi-Automated Urine Analyzers are Used Extensively Due to Their Low Cost and Ease of Use
6.3.3 Point-Of-Care Urine Analyzers
6.3.3.1 Need for Rapid Testing to Drive the Demand for Poc Devices
7 Urinalysis Market, by Test Type
7.1 Introduction
7.2 Pregnancy & Fertility Tests
7.2.1 Rising Incidence of Accidental Pregnancies to Drive the Growth of This Segment
7.3 Biochemical Urinalysis
7.3.1 Laboratory Tests
7.3.1.1 Increasing Incidence of Urinary Tract Infections and Kidney Diseases to Drive the Growth of This Segment
7.3.2 Point-Of-Care Tests
7.3.2.1 Ease and Convenience of Poc Poc Testing to Drive the Growth of This Segment During the Forecast Period
7.4 Sediment Urinalysis
7.4.1 Increasing Adoption of Automated Analyzers to Drive the Growth of This Segment
8 Urinalysis Market, by Application
8.1 Introduction
8.2 Disease Screening
8.2.1 Urinary Tract Infections
8.2.1.1 Increasing Prevalence of Utis to Drive Growth in the Urinalysis Market for Disease Screening
8.2.2 Kidney Diseases
8.2.2.1 Rapidly Growing Global Geriatric Population and the Subsequent Increase in the Prevalence of Kidney Diseases to Drive Market Growth
8.2.3 Diabetes
8.2.3.1 Development of Advanced Analytical Tools for Diabetes Will Drive Market Growth
8.2.4 Liver Diseases
8.2.4.1 High Prevalence of Liver Diseases Will Increase the Demand for Urinalysis
8.2.5 Other Disease Screening Applications
8.3 Pregnancy & Fertility
8.3.1 Need for Early Detection of Pregnancy & Fertility to Drive Growth in the Urinalysis Market
9 Urinalysis Market, by End User
9.1 Introduction
9.2 Hospitals & Clinics
9.2.1 Increase in Hospitalizations for Urinary Diseases to Drive Growth in This End-User Segment
9.3 Diagnostic Laboratories
9.3.1 Large Number of Diagnostic Laboratories Carrying Out Tests Globally to Drive Market Growth
9.4 Home Care Settings
9.4.1 Widespread Use of Pregnancy Kits in Home Care Settings to Drive Market Growth
9.5 Research Laboratories & Institutes
9.5.1 Research in Developing New Urinalysis Kits for Disease Diagnosis Will Drive Market Growth
10 Urinalysis Market, by Region
11 Competitive Landscape
11.1 Overview
11.2 Market Ranking Analysis, 2018
11.3 Key Strategies
11.3.1 Product Launches, 2016-2018
11.3.2 Expansions, 2016-2018
11.3.3 Partnerships, 2016-2018
11.4 Competitive Leadership Mapping (2018)
11.4.1 Vendor Inclusion Criteria
11.4.2 Visionary Leaders
11.4.3 Innovators
11.4.4 Dynamic Differentiators
11.4.5 Emerging Companies
11.5 Competitive Leadership Mapping for Start-Ups (2018)
11.5.1 Progressive Companies
11.5.2 Starting Blocks
11.5.3 Responsive Companies
11.5.4 Dynamic Companies
12 Company Profiles
12.1 Cardinal Health, Inc.
12.2 Alere, Inc. (A Part of Abbott Laboratories)
12.3 Siemens Healthineers
12.4 Roche Diagnostics
12.5 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
12.6 Sysmex Corporation
12.7 Quidel Corporation
12.8 Bio-Rad Laboratories, Inc.
12.9 Arkray, Inc.
12.10 Acon Laboratories, Inc.
12.11 77 Elektronika Kft
12.12 Urit Medical Electronic Group Co., Ltd.
12.13 Dirui Industrial Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/82n8k7
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.